Update on Development of FSA’s Public List

On Friday 26 March 2021, ACI representatives met with the FSA for clarification relating to the novel foods validation process and the publication of the list that they mentioned in their update on 12 March.

[Pharmacy Business Magazine] Industry body welcomes FSA update on CBD products

Pharmacy Business Magazine reports that the FSA updated the criteria for CBD products which can remain on sale from 1 April 2021. Previously, only products which were on sale at the time of the FSA’s announcement (13 February 2020) and were linked to an application which had been validated by 31 March 2021 were to be included.

[Analytical Cannabis] The UK’s Food Standards Agency Updates its CBD Novel Foods Criteria

Last February, the Food Standards Agency (FSA) announced that all CBD businesses operating in England and Wales must have a novel foods application “validated” by March 31, 2021, or risk having their CBD oils, drinks, and treats “taken off the shelves.” Now, with just over two weeks left until the deadline, the FSA has clarified that all applications just have to be “submitted” by March 31, 2021.